<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "thiotepa inj VIAL">
<dose><value>60</value>
</dose><route><value>INTRAVESICALLY</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>thiotepa inj VIAL</value>
</drugname><strength><value>15 mg</value>
</strength><frequency><value>WEEKLY</value>
</frequency><instruction><value>for 4 weeks. Retain solution for 2 hours.</value>
</instruction><volume><value></value>
</volume><units><value>mg</value>
</units><additionalnotes><value>Bladder Cancer. Dilute dose in 30 to 60 mL 0.9% sodium chloride.</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3340</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary, Health Canada Special Access Programme.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>